These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11249554)

  • 21. [Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
    Iakovlev VP; Svetukhin AM; Blatun LA; Ukhin SA
    Antibiot Khimioter; 2004; 49(8-9):57-65. PubMed ID: 15727148
    [No Abstract]   [Full Text] [Related]  

  • 22. Moxifloxacin: new preparation. A me-too with more cardiac risks.
    Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections.
    Nakamori Y; Miyashita Y; Nakatani I; Nakata K
    Drugs; 1995; 49 Suppl 2():418-9. PubMed ID: 8549384
    [No Abstract]   [Full Text] [Related]  

  • 24. [Levofloxacin in the treatment of respiratory infections].
    Iakovlev SV; Iakovlev VP
    Antibiot Khimioter; 2002; 47(8):32-42. PubMed ID: 12515095
    [No Abstract]   [Full Text] [Related]  

  • 25. [Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].
    Budanov SV; Smirnova LB
    Antibiot Khimioter; 2001; 46(5):31-8. PubMed ID: 11558453
    [No Abstract]   [Full Text] [Related]  

  • 26. New generations of quinolones: with particular attention to levofloxacin.
    Ambrose PG; Owens RC; Quintiliani R; Nightingale CH
    Conn Med; 1997 May; 61(5):269-72. PubMed ID: 9197076
    [No Abstract]   [Full Text] [Related]  

  • 27. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.
    Preston SL; Drusano GL; Berman AL; Fowler CL; Chow AT; Dornseif B; Reichl V; Natarajan J; Corrado M
    JAMA; 1998 Jan; 279(2):125-9. PubMed ID: 9440662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Observational study investigating the use of levofloxacin in ICU patients].
    Alvarez-Lerma F; Palomar M; Olaechea P; León C; Sánchez M; Bermejo B;
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):220-6. PubMed ID: 15056438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gatifloxacin: a review of its use in the management of bacterial infections.
    Perry CM; Ormrod D; Hurst M; Onrust SV
    Drugs; 2002; 62(1):169-207. PubMed ID: 11790160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae.
    Ambrose PG; Grasela DM
    Diagn Microbiol Infect Dis; 2000 Nov; 38(3):151-7. PubMed ID: 11109013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levofloxacin revisited.
    Med Lett Drugs Ther; 2011 Jul; 53(1368):55. PubMed ID: 21738109
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.
    Pea F; Di Qual E; Cusenza A; Brollo L; Baldassarre M; Furlanut M
    Clin Pharmacokinet; 2003; 42(6):589-98. PubMed ID: 12793843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.
    Onrust SV; Lamb HM; Balfour JA
    Drugs; 1998 Nov; 56(5):895-928. PubMed ID: 9829160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora.
    Edlund C; Sjöstedt S; Nord CE
    Scand J Infect Dis; 1997; 29(4):383-6. PubMed ID: 9360254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of side effects of levofloxacin versus other fluoroquinolones.
    Carbon C
    Chemotherapy; 2001; 47 Suppl 3():9-14; discussion 44-8. PubMed ID: 11549784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient.
    Schwalm JD; Lee CH
    CMAJ; 2003 Apr; 168(7):847-8. PubMed ID: 12668542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of levofloxacin 200 mg 3 times daily in the treatment of bacterial lower respiratory tract infections.
    Kawai T
    Drugs; 1995; 49 Suppl 2():416-7. PubMed ID: 8549383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.